CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous-cell carcinoma of the esophagus

International Journal of Cancer

Volumn 71, Issue 2, 1997, Pages 192-195

  Morita, Shunji ^a   Yano, Masahiko ^a   Shiozaki, Hitoshi ^a   Tsujinaka, Toshimasa ^b   Ebisui, Chikara ^a   Morimoto, Takashi ^a   Kishibuti, Masanori ^a   Fujita, Junya ^a   Ogawa, Atsuhiro ^a   Taniguchi, Masaaki ^a   Inoue, Masatoshi ^a   Tamura, Shigeyuki ^a   Yamazaki, Keiji ^c   Kikkawa, Nobuteru ^d   Mizunoya, Sumio ^e   Monden, Morito ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b TOYONAKA MUNICIPAL HOSPITAL   (Japan)

^c KANSAI ROSAI HOSPITAL   (Japan)

^d OSAKA NATIONAL HOSPITAL   (Japan)

^e Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CYTOCHROME P450 ISOENZYME; DNA; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; CONTROLLED STUDY; DNA POLYMORPHISM; ESOPHAGUS CARCINOMA; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TOBACCO;

ADULT; AGE OF ONSET; AGED; CARCINOMA, SQUAMOUS CELL; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2E1; DISEASE SUSCEPTIBILITY; DNA PRIMERS; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0030967278     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970410)71:2<192::AID-IJC11>3.0.CO;2-K     Document Type: Article

References (21)

1. ANTTILA, S., HIETANEN, E., VAINIO, H., CAMUS, A.-M., GELBOIN, H.V., PARK, S.S., HEIKKILÄ, L., KARJARAINEN, A. and BARTSCH, H., Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IA in lung cancer patients. Int. J. Cancer, 47, 681-685 (1991).
2. COSMA, G., CROFTS, F., TAIOLI, E., TONIOLO, R and GARTE, S., Relationship between genotype and function of the human CYP1A1 gene. J. Toxicol. environ. Hlth, 40, 309-316 (1993).
3. CROFTS, F., COSMA, G.N., CURRIE, D., TAIOLI, E., TONIOLO, P. and GARTE, S.J., A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis. 14, 1729-1731 (1993).
4. DOLL, R. and PETO, R., The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. nat. Cancer Inst., 66, 1191-1308 (1981).
5. GROPPI, A., COUTELLE, C., FLEURY, B., IRON, A., BEGUERET, J. and COUZIGOU, P., Glutathione S-transferase class μ in French alcoholic cirrhotic patients. Hum. Genet., 87, 628-630 (1991).
6. HAYASHI, S.-I., WATANABE, J. and KANAME, K., High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and mu-class glutathione S-transferase genes. Jap. J. Cancer Res., 83, 866-870 (1992).
7. HAYASHI, S.-I., WATANABE, J. and KAWAJIRI, K., Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J. Biochem., 110, 559-565 (1991a).
8. HAYASHI, S.-I., WATANABE, J., NAKACHI, K. and KAWAJIRI, K., Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. J. Biochem., 110, 407-411 (1991b).
9. KATO, S., BOWMAN, E.D., HARRINGTON, A.M., BLOMEKE, B. and SHIELDS, P.G., Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J. nat. Cancer Inst., 87, 902-907 (1995).
10. KATOH, T., INATOMI, H., NAGAOKA, A. and SUGITA, A., Cytochrome P4501A1 gene polymorphism and homozygous deletion of the glutathione S-transferase M1 gene in urothelial cancer patients. Carcinogenesis, 16, 655-657 (1995).
11. KAWAJIRI, K., NAKACHI, K., IMAI, K., YOSHII, A., SHINODA, N. and WATANABE, J., Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IAI gene. FEBS Lett., 263, 131-133 (1990).
12. KIHARA, M., KIHARA, M. and NODA, K., Risk of smoking for squamous and small-cell carcinomas of the lung modulated by combinations of CYP1A1 and GSTM1 gene polymorphisms in a Japanese population. Carcinogenesis, 16, 2331-2336 (1995).
13. KIM, R.B., O'SHEA, D. and WILKINSON, G.R., Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms. Clin. Pharmacol. Ther., 57, 645-655 (1995).
14. NAKAJIMA, T., WANG, R.-S., NIMURA,Y., PIN, Y.-M., HE, M., VAINIO, H., MURAYAMA, N., AOYAMA, T. and IIDA, F., Expression of cytochrome P450s and glutathione S-transferases in human esophagus with squamous-cell carcinomas. Carcinogenesis, 17, 1477-1481 (1996).
15. PERROT, N., NALPAS, B., YANG, C.S. and BEAUNE, P.H., Modulation of cytochrome P450 isozymes in human liver, by ethanol and drug intake. Europ. J. clin. Invest., 19, 549-555 (1989).
16. RAUNIO, H., HUSGAFVEL-PURSIAINEN, K., ANTTILA, S., HIKTANEN, E., HIRVONEN, A. and PELKONEN, O., Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility - a review. Gene, 159, 113-121 (1995).
17. TAIOLI, E., CROPS, F., TRACHMAN, J., BAYO, S., TONIOLO, P. and GARTH, S.J., Racial differences in CYP1A1 genotype and function. Toxicol Lett., 77, 357-362 (1995).
18. UEMATSU, R. KIKUCHI, H., MOTOMIYA, M., TATSUYA, A., SAGAMI, I., OHMACHI, T., WAKUI, A., KANAMURA, R. and WATANABE, M., Association between restriction fragment length polymorphism of the human cytochrome P450IIIE1 gene and susceptibility to lung cancer. Jap. J. Cancer Res., 82, 254-256 (1991).
19. WATANABE, J., HAYASHI, S.-I. and KAWAJIRI, K., Different regulation and expression of the human CYP2E1 gene due to the RasI polymorphism in the 5′-flanking region. J. Biochem., 116, 321-326 (1994).
20. WEDLUND, P.J., KIMURA, S., GONZALEZ, F.J. and NEBERT, D.W., 1462V mutation in the human CYP1A1 gene: lack of correlation with either the MspI 1.9 kb (M2) allele or CYP1A1 inducibility in a three-generation family of cast Mediterranean descent. Pharmacogenetics, 4, 21-26 (1994).
21. 462: assessment of a role for the rare allele in carcinogenesis. Cancer., 56, 3926-3933 (1996).